Lila Sciences was last valued at $8.5B (pre-money). It comes from the $2B Series B of Jun 2026. The company is private, so there is no listed share price.
1 valuation. The latest, $8.5B pre-money, was set by the Series B in Jun 2026.
A private valuation is the price agreed in one transaction. The Lila Sciences valuation of $8.5B is a pre-money figure from the Series B dated 1 Jun 2026 .
The valuation holds until the next priced round or secondary sale. A private company founded in 2025 with roughly 415 people has no daily price and no order book between rounds.
The routes section explains what is realistically available for a company at this stage.
No. Lila Sciences is a private company; its shares do not trade on a public exchange.
The closest biotechnology / ai peers are on the competitors page.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
